Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0031974 | membrane-enclosed lumen | 2 | 2 |
GO:0031981 | nuclear lumen | 5 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0043233 | organelle lumen | 3 | 2 |
GO:0070013 | intracellular organelle lumen | 4 | 2 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
GO:0005634 | nucleus | 5 | 4 |
GO:0043226 | organelle | 2 | 4 |
GO:0043227 | membrane-bounded organelle | 3 | 4 |
GO:0043229 | intracellular organelle | 3 | 4 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 4 |
Related structures:
AlphaFold database: Q4QCV7
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 6 |
GO:0043167 | ion binding | 2 | 6 |
GO:0043169 | cation binding | 3 | 6 |
GO:0046872 | metal ion binding | 4 | 6 |
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003746 | translation elongation factor activity | 4 | 1 |
GO:0008135 | translation factor activity, RNA binding | 3 | 1 |
GO:0045182 | translation regulator activity | 1 | 1 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 220 | 224 | PF00656 | 0.631 |
CLV_C14_Caspase3-7 | 269 | 273 | PF00656 | 0.568 |
CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.673 |
CLV_NRD_NRD_1 | 154 | 156 | PF00675 | 0.659 |
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.588 |
CLV_NRD_NRD_1 | 44 | 46 | PF00675 | 0.606 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.673 |
CLV_PCSK_KEX2_1 | 156 | 158 | PF00082 | 0.670 |
CLV_PCSK_KEX2_1 | 44 | 46 | PF00082 | 0.618 |
CLV_PCSK_PC1ET2_1 | 156 | 158 | PF00082 | 0.670 |
DOC_CKS1_1 | 232 | 237 | PF01111 | 0.700 |
DOC_MAPK_MEF2A_6 | 69 | 76 | PF00069 | 0.385 |
DOC_PP4_FxxP_1 | 61 | 64 | PF00568 | 0.385 |
DOC_USP7_MATH_1 | 101 | 105 | PF00917 | 0.385 |
DOC_USP7_UBL2_3 | 156 | 160 | PF12436 | 0.652 |
DOC_WW_Pin1_4 | 231 | 236 | PF00397 | 0.826 |
LIG_14-3-3_CanoR_1 | 73 | 77 | PF00244 | 0.385 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.692 |
LIG_BIR_III_2 | 223 | 227 | PF00653 | 0.632 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.628 |
LIG_FHA_1 | 202 | 208 | PF00498 | 0.676 |
LIG_FHA_1 | 50 | 56 | PF00498 | 0.562 |
LIG_FHA_1 | 69 | 75 | PF00498 | 0.250 |
LIG_FHA_2 | 218 | 224 | PF00498 | 0.631 |
LIG_HCF-1_HBM_1 | 38 | 41 | PF13415 | 0.633 |
LIG_LIR_Apic_2 | 60 | 64 | PF02991 | 0.385 |
LIG_LIR_Gen_1 | 124 | 130 | PF02991 | 0.495 |
LIG_LIR_Gen_1 | 247 | 257 | PF02991 | 0.709 |
LIG_LIR_Nem_3 | 117 | 122 | PF02991 | 0.218 |
LIG_LIR_Nem_3 | 124 | 129 | PF02991 | 0.425 |
LIG_LIR_Nem_3 | 247 | 253 | PF02991 | 0.797 |
LIG_LIR_Nem_3 | 99 | 105 | PF02991 | 0.385 |
LIG_LYPXL_yS_3 | 102 | 105 | PF13949 | 0.385 |
LIG_MYND_3 | 109 | 113 | PF01753 | 0.385 |
LIG_REV1ctd_RIR_1 | 117 | 125 | PF16727 | 0.385 |
LIG_SH2_CRK | 126 | 130 | PF00017 | 0.448 |
LIG_SH2_STAP1 | 126 | 130 | PF00017 | 0.491 |
LIG_SH2_STAT5 | 89 | 92 | PF00017 | 0.385 |
LIG_SH3_3 | 223 | 229 | PF00018 | 0.678 |
LIG_SH3_3 | 232 | 238 | PF00018 | 0.635 |
LIG_SH3_3 | 4 | 10 | PF00018 | 0.627 |
LIG_SH3_3 | 92 | 98 | PF00018 | 0.342 |
LIG_TYR_ITIM | 100 | 105 | PF00017 | 0.385 |
LIG_WRC_WIRS_1 | 58 | 63 | PF05994 | 0.385 |
LIG_WW_3 | 236 | 240 | PF00397 | 0.666 |
MOD_CDC14_SPxK_1 | 236 | 239 | PF00782 | 0.666 |
MOD_CDK_SPxK_1 | 233 | 239 | PF00069 | 0.674 |
MOD_CK1_1 | 14 | 20 | PF00069 | 0.568 |
MOD_CK1_1 | 233 | 239 | PF00069 | 0.827 |
MOD_CK1_1 | 27 | 33 | PF00069 | 0.643 |
MOD_CK1_1 | 68 | 74 | PF00069 | 0.385 |
MOD_CK2_1 | 173 | 179 | PF00069 | 0.607 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.662 |
MOD_GSK3_1 | 138 | 145 | PF00069 | 0.628 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.582 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.683 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.385 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.264 |
MOD_NEK2_2 | 89 | 94 | PF00069 | 0.385 |
MOD_PKA_1 | 11 | 17 | PF00069 | 0.537 |
MOD_PKA_2 | 11 | 17 | PF00069 | 0.537 |
MOD_PKA_2 | 72 | 78 | PF00069 | 0.372 |
MOD_Plk_1 | 37 | 43 | PF00069 | 0.621 |
MOD_ProDKin_1 | 231 | 237 | PF00069 | 0.823 |
MOD_SUMO_rev_2 | 62 | 71 | PF00179 | 0.320 |
TRG_ENDOCYTIC_2 | 102 | 105 | PF00928 | 0.442 |
TRG_ENDOCYTIC_2 | 126 | 129 | PF00928 | 0.576 |
TRG_ER_diArg_1 | 10 | 12 | PF00400 | 0.661 |
TRG_ER_diArg_1 | 44 | 46 | PF00400 | 0.618 |
TRG_NLS_MonoExtC_3 | 17 | 23 | PF00514 | 0.673 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IBM0 | Leishmania donovani | 89% | 100% |
A4HYT1 | Leishmania infantum | 90% | 100% |
E9AIE0 | Leishmania braziliensis | 69% | 100% |
E9AUM7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |